Metastatic Timing and Genetic Heterogeneity in the Evolution of a Pancreatic Neuroendocrine Tumor

Am J Gastroenterol. 2021 Apr;116(4):844-847. doi: 10.14309/ajg.0000000000001004.

Authors

Xia Tang¹, Yue Shao, Xin Yi, Paul J Newey, Dewei Li, Keyue Ding; Gastrointestinal Cancer Evolution Study Group

Affiliation

¹ 1Department of Bioinformatics, School of Basic Medicine, Chongqing Medical University, Chongqing, China; 2Department of Hepatobiliary Surgery, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China; 3Geneplus-Beijing Institute, Beijing, China; 4Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom.

PMID: 33982971
DOI: 10.14309/ajg.0000000000001004

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Case-Control Studies
Gastrointestinal Hemorrhage
Genetic Heterogeneity
Humans
Neuroendocrine Tumors* / genetics
Pancreatic Neoplasms* / genetics
SARS-CoV-2